BioSpace News Archive

AEEC was a sponsor of the San Diego Supercomputer Center’s (SDSC) fourth annual Data West Technology Forum, held on December 10th and 11th at the Sanford Consortium for Regenerative Medicine.

Crossover Health, a digital-first, national medical group, today announced the results of a study that found individuals who suffer from imposter syndrome tend to experience lower job satisfaction, higher burnout, and perform poorly at work.

MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it has closed the underwritten public offering of 32,343,750 shares of its common stock, including 4,218,750 shares sold as a result of the exercise by the underwriters of their option to purchase additional shares,

POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced that company management will participate at the ODDO BHF Forum, which is being held on January 9-10, 2020, in Lyon, France.

Kinnate Biopharma, Inc., a precision oncology company focused on the discovery and development of novel kinase inhibitors, announced today that the company raised $74.5M in an oversubscribed Series B financing

HealthRIGHT 360 announced today the successful issuance of nearly $50 million in Social Bonds.

ModifyHealth™ is making a significant impact on health outcomes as the first company to offer nationwide delivery of fully-prepared, low-FODMAP, and gluten-free meals.

Capricor Therapeutics, Inc. announced the closing of the previously announced offering priced at-the-market of 4,139,477 shares of the Company’s common stock, at a purchase price of $1.226 per share and associated warrant.

Patrick Henning to lead CLSA’s Federal, State and Local Government Relations, Communications, Policy and Alliance Development Efforts on behalf of California’s life sciences sector

MCNA Dental announced that it has been awarded a contract by Texas Health and Human Services to continue to provide dental managed care to enrollees in the Texas Medicaid and CHIP Dental Services programs.